BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Richard S. Kalman, Kevan Hartshorn, Francis A. Farraye. Does a Personal or Family History of Malignancy Preclude the Use of Immunomodulators and Biologics in IBDInflammatory Bowel Diseases 2015; 21(2): 428 doi: 10.1097/MIB.0000000000000211
2
Sara Lombardi, Ilenia Fuoco, Giorgia di Fluri, Francesco Costa, Angelo Ricchiuti, Graziano Biondi, Vincenzo Nardini, Roberto Scarpato. Genomic instability and cellular stress in organ biopsies and peripheral blood lymphocytes from patients with colorectal cancer and predisposing pathologiesOncotarget 2015; 6(17): 14852 doi: 10.18632/oncotarget.4032
3
Carol J. Díaz-Díaz, Sean M. Ronnekleiv-Kelly, Manabu Nukaya, Peter G. Geiger, Silvia Balbo, Romel Dator, Bryant W. Megna, Patrick R. Carney, Christopher A. Bradfield, Gregory D. Kennedy. The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in MouseAnnals of Surgery 2016; 264(3): 429 doi: 10.1097/SLA.0000000000001874
4
Abdelhamed Haram, Michael R. Boland, Michael E. Kelly, Jarlath C. Bolger, Ronan M. Waldron, Michael J. Kerin. The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic reviewJournal of Surgical Oncology 2017; 115(4): 470 doi: 10.1002/jso.24523
5
Sushil K. Garg, Fernando S. Velayos, John B. Kisiel. Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's DiseaseGastroenterology Clinics of North America 2017; 46(3): 515 doi: 10.1016/j.gtc.2017.05.006
6
Marina Pierdominici, Angela Maselli, Barbara Varano, Cristiana Barbati, Paola Cesaro, Cristiano Spada, Angelo Zullo, Roberto Lorenzetti, Marco Rosati, Gabriella Rainaldi, Maria Rosaria Limiti, Luisa Guidi, Lucia Conti, Sandra Gessani. Linking estrogen receptor β expression with inflammatory bowel disease activityOncotarget 2015; 6(38): 40443 doi: 10.18632/oncotarget.6217
7
Fei Mao, Yunbing Wu, Xudong Tang, Jingjing Kang, Bin Zhang, Yongmin Yan, Hui Qian, Xu Zhang, Wenrong Xu. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in MiceBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5356760
8
Ashwin N. Ananthakrishnan, Andrew Cagan, Tianxi Cai, Vivian S. Gainer, Stanley Y. Shaw, Susanne Churchill, Elizabeth W. Karlson, Shawn N. Murphy, Isaac Kohane, Katherine P. Liao. Colonoscopy Is Associated With a Reduced Risk for Colon Cancer and Mortality in Patients With Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology 2015; 13(2): 322 doi: 10.1016/j.cgh.2014.07.018
9
Vikram Kanagala, Daniel J. Stein. Inflammatory Bowel Disease2015; : 41 doi: 10.1007/978-3-319-14072-8_7
10
Chelle L. Wheat, Kindra Clark-Snustad, Beth Devine, David Grembowski, Timothy A. Thornton, Cynthia W. Ko. Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-AnalysisGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/1632439
11
Ali Gökyer, Ahmet Küçükarda, Sezin Sayın, Fatma Elif Usturalı Keskin, İrfan Çiçin. Stage I colon cancer that spreads into a colovesical fistula-mediated bladder due to crohn's disease: A case reportCurrent Problems in Cancer: Case Reports 2020; 1: 100010 doi: 10.1016/j.cpccr.2020.100010
12
Luca Roncucci, Francesco Mariani. Prevention of colorectal cancer: How many tools do we have in our basket?European Journal of Internal Medicine 2015; 26(10): 752 doi: 10.1016/j.ejim.2015.08.019
13
R. A. Stein. Streptococcus infantariusand carcinogenesis: a new chapter in colorectal pathologyInternational Journal of Clinical Practice 2013; 67(12): 1220 doi: 10.1111/ijcp.12295
14
Timothy Card, Ryan Ungaro, Fatima Bhayat, Aimee Blake, Gary Hantsbarger, Simon Travis. Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing dataAlimentary Pharmacology & Therapeutics 2020; 51(1): 149 doi: 10.1111/apt.15538
15
Sung Hee Kim, Eun Ju Shin, Haeng Jeon Hur, Jae Ho Park, Mi Jeong Sung, Dae Young Kwon, Jin-Taek Hwang. Citrus junos Tanaka peel extract attenuates experimental colitis and inhibits tumour growth in a mouse xenograft modelJournal of Functional Foods 2014; 8: 301 doi: 10.1016/j.jff.2014.03.024
16
Anastasiya V. Snezhkina, George S. Krasnov, Anastasiya V. Lipatova, Asiya F. Sadritdinova, Olga L. Kardymon, Maria S. Fedorova, Nataliya V. Melnikova, Oleg A. Stepanov, Andrew R. Zaretsky, Andrey D. Kaprin, Boris Y. Alekseev, Alexey A. Dmitriev, Anna V. Kudryavtseva. The Dysregulation of Polyamine Metabolism in Colorectal Cancer Is Associated with Overexpression of c-Myc and C/EBPβrather than EnterotoxigenicBacteroides fragilisInfectionOxidative Medicine and Cellular Longevity 2016; 2016: 1 doi: 10.1155/2016/2353560
17
Guangzhao Guan, Li Mei, Ajith Polonowita, Haizal Hussaini, Benedict Seo, Alison Mary Rich. Malignant transformation in oral lichen planus and lichenoid lesions: a 14-year longitudinal retrospective cohort study of 829 patients in New ZealandOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2020;  doi: 10.1016/j.oooo.2020.07.002
18
Junko Kishikawa, Kazushige Kawai, Nelson H. Tsuno, Soichiro Ishihara, Hironori Yamaguchi, Eiji Sunami, Toshiaki Watanabe. Characteristics and Prognosis of Colorectal Cancer Associated With Rheumatic DiseaseInternational Surgery 2015; 100(5): 783 doi: 10.9738/INTSURG-D-14-00154.1
19
Wolf H. Fridman, Ian Miller, Catherine Sautès-Fridman, Annette T. Byrne. Therapeutic Targeting of the Colorectal Tumor StromaGastroenterology 2020; 158(2): 303 doi: 10.1053/j.gastro.2019.09.045
20
Diagnostic Pathology: Gastrointestinal2016; : 500 doi: 10.1016/B978-0-323-37673-0.50143-9
21
A. Lamarca Lete, R. Molina Villaverde, J.L. López González, M. Álvarez-Mon Soto. Cáncer colorrectalMedicine - Programa de Formación Médica Continuada Acreditado 2013; 11(25): 1519 doi: 10.1016/S0304-5412(13)70488-8
22
Elisa Giner, M. Carmen Recio, José Luis Ríos, José Miguel Cerdá-Nicolás, Rosa María Giner. Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 miceMolecular Nutrition & Food Research 2016; 60(2): 242 doi: 10.1002/mnfr.201500605
23
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancerJournal of Coloproctology 2017; 37(1): 55 doi: 10.1016/j.jcol.2016.06.005
24
Javier Ávila-Román, Elena Talero, Carolina de los Reyes, Eva Zubía, Virginia Motilva, Sofía García-Mauriño. Cytotoxic Activity of Microalgal-derived Oxylipins against Human Cancer Cell lines and their Impact on ATP LevelsNatural Product Communications 2016; 11(12): 1934578X1601101 doi: 10.1177/1934578X1601101225
25
Samuel C. L. Smith, Rosanna Cannatelli, Alina Bazarova, Neel Sharma, Adam McCulloch, Jason Mak, Uday N. Shivaji, Tariq Iqbal, Kate Kane, Subrata Ghosh, Rachel Cooney, Marietta Iacucci. Performance measures in inflammatory bowel disease surveillance colonoscopy: Implementing changes to practice improves performanceDigestive Endoscopy 2020; 32(4): 592 doi: 10.1111/den.13521
26
Maciej Sałaga, Hubert Zatorski, Marta Sobczak, Chunqiu Chen, Jakub Fichna. Chinese Herbal Medicines in the Treatment of IBD and Colorectal Cancer: A ReviewCurrent Treatment Options in Oncology 2014; 15(3): 405 doi: 10.1007/s11864-014-0288-2
27
Myrna L. Ortiz, Vinit Kumar, Anna Martner, Sridevi Mony, Laxminarasimha Donthireddy, Thomas Condamine, John Seykora, Stella C. Knight, George Malietzis, Gui Han Lee, Morgan Moorghen, Brianna Lenox, Noreen Luetteke, Esteban Celis, Dmitry Gabrilovich. Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17–producing CD4+ T cellsJournal of Experimental Medicine 2015; 212(3): 351 doi: 10.1084/jem.20140835
28
Noel Pabalan, Eloisa Singian, Lani Tabangay, Hamdi Jarjanazi, Neetu Singh. Associations of theA66GMethionine Synthase Reductase Polymorphism in Colorectal Cancer: A Systematic Review and Meta-AnalysisBiomarkers in Cancer 2015; : BIC.S25251 doi: 10.4137/BIC.S25251
29
R. Molina Villaverde, A.M. Jiménez Gordo, M. López Gómez, M. Álvarez-Mon Soto. Cáncer colorrectalMedicine - Programa de Formación Médica Continuada Acreditado 2017; 12(32): 1911 doi: 10.1016/j.med.2017.04.012
30
Emilia Bareggi, Michela Monteleone. Imaging of Ulcerative Colitis2014; : 5 doi: 10.1007/978-88-470-5409-7_2
31
Andrew V Nguyen, Yuan-Yuan Wu, Elaine Y Lin. STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancerWorld Journal of Gastroenterology 2014; 20(30): 10279-10287 doi: 10.3748/wjg.v20.i30.10279
32
A. DE LERMA BARBARO, G. PERLETTI, I.M. BONAPACE, E. MONTI. Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review)International Journal of Oncology 2014; 45(3): 959 doi: 10.3892/ijo.2014.2490
33
Marta Sobczak, Marcin Wlazłowski, Hubert Zatorski, Maciej Sałaga, Jakub Fichna. Current overview of colitis-associated colorectal cancerOpen Life Sciences 2014; 9(11): 1022 doi: 10.2478/s11535-014-0345-7
34
J. Claire Wilson, Raoul I. Furlano, Susan S. Jick, Christoph R. Meier. A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel diseaseJournal of Gastroenterology 2016; 51(11): 1050 doi: 10.1007/s00535-016-1199-8
35
Y.-C. Peng, C.-L. Lin, W.-Y. Hsu, C.-S. Chang, H.-Z. Yeh, S.-C. Liao, C.-H. Kao. The risk of colorectal cancer is related to frequent hospitalization of IBD in an Asian population: results from a nationwide studyQJM 2015; 108(6): 457 doi: 10.1093/qjmed/hcu225
36
Nitin Tandra, Peipei Wu, Xinyuan Hu, Fei Mao, Wenrong Xu, Hui Qian. Extracellular Vesicles: A New Nano Tool for the Treatment of Inflammatory Bowel DiseasesCurrent Nanoscience 2019; 15(6): 589 doi: 10.2174/1573413715666190411141126
37
Carlien Leyssens, Lieve Verlinden, Annemieke Verstuyf. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancerEndocrine-Related Cancer 2013; 20(2): R31 doi: 10.1530/ERC-12-0381
38
Hans-Olov Adami, Michael Bretthauer, Louise Emilsson, Miguel A Hernán, Mette Kalager, Jonas F Ludvigsson, Anders Ekbom. The continuing uncertainty about cancer risk in inflammatory bowel diseaseGut 2016; 65(6): 889 doi: 10.1136/gutjnl-2015-311003
39
Jiangtao Zhou, Tongtong Wang, Yaoxing Dou, Yanfeng Huang, Chang Qu, Jiansheng Gao, Zijian Huang, Youliang Xie, Ping Huang, Zhixiu Lin, Ziren Su. Brusatol ameliorates 2, 4, 6-trinitrobenzenesulfonic acid-induced experimental colitis in rats: Involvement of NF-κB pathway and NLRP3 inflammasomeInternational Immunopharmacology 2018; 64: 264 doi: 10.1016/j.intimp.2018.09.008
40
Beicheng Sun, Michael Karin. The therapeutic value of targeting inflammation in gastrointestinal cancersTrends in Pharmacological Sciences 2014; 35(7): 349 doi: 10.1016/j.tips.2014.04.011
41
Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, Doris Wagner, Kazunari Sasaki, Boris Galjart, Carsten Kamphues, Timothy M Pawlik, George Poultsides, Klaus Kaczirek, Per Eystein Lønning, Cornelis Verhoef, Martin E Kreis, Christopher L Wolfgang, Matthew J. Weiss. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysisJournal of Surgical Oncology 2018; 118(7): 1074 doi: 10.1002/jso.25251
42
B. Flood, K. Oficjalska, D. Laukens, J. Fay, A. O'Grady, F. Caiazza, Z. Heetun, K. H. G. Mills, K. Sheahan, E. J. Ryan, G. A. Doherty, E. Kay, E. M. Creagh. Altered expression of caspases‐4 and ‐5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potentialClinical & Experimental Immunology 2015; 181(1): 39 doi: 10.1111/cei.12617
43
Chaya Shwaartz, Jordan A. Munger, Juan R. Deliz, Joseph E. Bornstein, Stephan R. Gorfine, David B. Chessin, Daniel A. Popowich, Joel J. Bauer. Fistula-Associated Anorectal Cancer in the Setting of Crohn’s DiseaseDiseases of the Colon & Rectum 2016; 59(12): 1168 doi: 10.1097/DCR.0000000000000700
44
A C Bateman, P Patel. Lower gastrointestinal endoscopy: guidance on indications for biopsyFrontline Gastroenterology 2014; 5(2): 96 doi: 10.1136/flgastro-2013-100412
45
Elena L Paley. Diet-Related Metabolic Perturbations of Gut Microbial Shikimate Pathway-Tryptamine-tRNA Aminoacylation-Protein Synthesis in Human Health and DiseaseInternational Journal of Tryptophan Research 2019; 12: 117864691983455 doi: 10.1177/1178646919834550
46
Yoshiki Okita, Toshimitsu Araki, Koji Tanaka, Yuji Toiyama, Keiichi Uchida, Masato Kusunoki. Colitis-Associated Cancer2016; : 61 doi: 10.1007/978-4-431-55522-3_4
47
Magnus Hofrenning Wanderås, Bjørn A Moum, Marte Lie Høivik, Øistein Hovde. Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studiesWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(2): 235-241 doi: 10.4292/wjgpt.v7.i2.235
48
Eun Ran Kim, Dong Kyung Chang. Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosisWorld Journal of Gastroenterology 2014; 20(29): 9872-9881 doi: 10.3748/wjg.v20.i29.9872
49
Andrzej Hnatyszyn, Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Emilia Lis, Ryszard Słomski, Rodney J. Scott, Andrzej Pławski. Colorectal carcinoma in the course of inflammatory bowel diseasesHereditary Cancer in Clinical Practice 2019; 17(1) doi: 10.1186/s13053-019-0118-4
50
Dan Su, Yu-qiao Gao, Wei-bo Dai, Ying Hu, Yan-fen Wu, Quan-xi Mei. Helicteric Acid, Oleanic Acid, and Betulinic Acid, Three Triterpenes fromHelicteres angustifoliaL., Inhibit Proliferation and Induce Apoptosis in HT-29 Colorectal Cancer Cells via Suppressing NF-κB and STAT3 SignalingEvidence-Based Complementary and Alternative Medicine 2017; 2017: 1 doi: 10.1155/2017/5180707
51
Yang-An Wen, Xin Li, Tatiana Goretsky, Heidi L. Weiss, Terrence A. Barrett, Tianyan Gao. Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(10): 2013 doi: 10.1016/j.bbadis.2015.07.012
52
Chiara Fazio, Giulia Piazzi, Paola Vitaglione, Vincenzo Fogliano, Alessandra Munarini, Anna Prossomariti, Maddalena Milazzo, Leonarda D’Angelo, Manuela Napolitano, Pasquale Chieco, Andrea Belluzzi, Franco Bazzoli, Luigi Ricciardiello. Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cellsScientific Reports 2016; 6(1) doi: 10.1038/srep20670
53
Ashwin N. Ananthakrishnan, Andrew Cagan, Tianxi Cai, Vivian S. Gainer, Stanley Y. Shaw, Susanne Churchill, Elizabeth W. Karlson, Shawn N. Murphy, Katherine P. Liao, Isaac Kohane. Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology 2016; 14(7): 973 doi: 10.1016/j.cgh.2016.02.017
54
Xinyun Qiu, Jingjing Ma, Kai Wang, Hongjie Zhang. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysisOncotarget 2017; 8(1): 1031 doi: 10.18632/oncotarget.13715
55
Noa Stettner, Chava Rosen, Biana Bernshtein, Shiri Gur-Cohen, Julia Frug, Alon Silberman, Alona Sarver, Narin N. Carmel-Neiderman, Raya Eilam, Inbal Biton, Meirav Pevsner-Fischer, Niv Zmora, Alexander Brandis, Keren Bahar Halpern, Ram Mazkereth, Diego di Bernardo, Nicola Brunetti-Pierri, Muralidhar H. Premkumar, Gillian Dank, Sandesh C.S. Nagamani, Steffen Jung, Alon Harmelin, Ayelet Erez. Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon CancerCell Reports 2018; 23(7): 1962 doi: 10.1016/j.celrep.2018.04.053
56
Sojoong Choi, Heesung Chung, Heejeong Hong, So Yeon Kim, Seong‐Eun Kim, Ju‐Young Seoh, Chang Mo Moon, Eun Gyeong Yang, Eok‐Soo Oh. Inflammatory hypoxia induces syndecan‐2 expression through IL‐1b–mediated FOXO3a activation in colonic epitheliaThe FASEB Journal 2017; 31(4): 1516 doi: 10.1096/fj.201601098R
57
Nicolas A. Giraldo, Etienne Becht, Yann Vano, Catherine Sautès-Fridman, Wolf H. Fridman. The immune response in cancer: from immunology to pathology to immunotherapyVirchows Archiv 2015; 467(2): 127 doi: 10.1007/s00428-015-1787-7
58
William Becker, Haider Rasheed Alrafas, Kiesha Wilson, Kathryn Miranda, Courtney Culpepper, Ioulia Chatzistamou, Guoshuai Cai, Mitzi Nagarkatti, Prakash S. Nagarkatti. Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 ProductioniScience 2020; 23(9): 101504 doi: 10.1016/j.isci.2020.101504
59
E. Israeli, S. Ying, B. Henderson, J. Mottola, T. Strome, C. N. Bernstein. The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2013; 38(5): 513 doi: 10.1111/apt.12410
60
Emma Altobelli, Giovanni Latella, Manrico Morroni, Caterina Licini, Giovanni Tossetta, Roberta Mazzucchelli, Valerio F. Profeta, Gino Coletti, Pietro Leocata, Mario Castellucci, Mario Guerrieri, Reimondo Petrocelli, Berardo De Berardis, Marina De Padova, Gabriella Di Leonardo, Antonella Paladini, Filippo Mignosi, Gina Quaglione, Roberto Fagnano, Daniela Marzioni. Low HtrA1 expression in patients with long-standing ulcerative colitis and colorectal cancerOncology Reports 2017; 38(1): 418 doi: 10.3892/or.2017.5700
61
Brisas M. Flores, Anthony O’Connor, Alan C. Moss. Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysisGastrointestinal Endoscopy 2017; 86(6): 1006 doi: 10.1016/j.gie.2017.07.028
62
Mohamed Salla, Rodrigo Aguayo-Ortiz, Gaddafi I. Danmaliki, Alaa Zare, Ahmed Said, Jack Moore, Vrajeshkumar Pandya, Robin Manaloor, Sunny Fong, Anna R. Blankstein, Spencer B. Gibson, Laura Ramos Garcia, Pascal Meier, Khushwant S. Bhullar, Basil P. Hubbard, Yahya Fiteh, Harissios Vliagoftis, Ing Swie Goping, Dion Brocks, Peter Hwang, Carlos A. Velázquez-Martínez, Shairaz Baksh. Identification and Characterization of Novel Receptor-Interacting Serine/Threonine‐Protein Kinase 2 Inhibitors Using Structural Similarity AnalysisJournal of Pharmacology and Experimental Therapeutics 2018; 365(2): 354 doi: 10.1124/jpet.117.247163
63
Anouk J.M. Rombouts, Niek Hugen, Marloes A.G. Elferink, Philip M.P. Poortmans, Iris D. Nagtegaal, Johannes H.W. de Wilt. Increased risk for second primary rectal cancer after pelvic radiation therapyEuropean Journal of Cancer 2020; 124: 142 doi: 10.1016/j.ejca.2019.10.022
64
Fumio Omata, Sachiko Ohde, Gautam A. Deshpande, Daiki Kobayashi, Katsunori Masuda, Tsuguya Fukui. Image-enhanced, chromo, and cap-assisted colonoscopy for improving adenoma/neoplasia detection rate: a systematic review and meta-analysisScandinavian Journal of Gastroenterology 2014; 49(2): 222 doi: 10.3109/00365521.2013.863964
65
Salim Amrani, Michael Polcino, Miguel Rodriguez-Bigas, Quyen D. Chu. Surgical Oncology2015; : 353 doi: 10.1007/978-1-4939-1423-4_16
66
Jon S. Thompson, Rebecca A. Weseman, David F. Mercer, Fedja A. Rochling, Luciano M. Vargas, Wendy J. Grant, Alan N. Langnas. Risk of Intestinal Malignancy in Patients With Short Bowel SyndromeJournal of Parenteral and Enteral Nutrition 2017; 41(4): 562 doi: 10.1177/0148607115609587
67
Dan Turner, Frank M. Ruemmele, Esther Orlanski-Meyer, Anne M. Griffiths, Javier Martin de Carpi, Jiri Bronsky, Gabor Veres, Marina Aloi, Caterina Strisciuglio, Christian P. Braegger, Amit Assa, Claudio Romano, Séamus Hussey, Michael Stanton, Mikko Pakarinen, Lissy de Ridder, Konstantinos Katsanos, Nick Croft, Victor Navas-López, David C. Wilson, Sally Lawrence, Richard K. Russell. Management of Paediatric Ulcerative Colitis, Part 1Journal of Pediatric Gastroenterology and Nutrition 2018; 67(2): 257 doi: 10.1097/MPG.0000000000002035
68
Lia Paola Zambetti, Alessandra Mortellaro. NLRPs, microbiota, and gut homeostasis: unravelling the connectionThe Journal of Pathology 2014; 233(4): 321 doi: 10.1002/path.4357
69
Alan Askari, Luis Sánchez Guillén, Monica Millan, Subramanian Nachiappan, Alex Bottle, Thanos Athanasiou, Omar Faiz. Colorectal tumour characteristics and oncological outcome in patients with inflammatory bowel diseaseSurgical Practice 2020; 24(2): 60 doi: 10.1111/1744-1633.12421
70
Jimmy K. Limdi, Francis A. Farraye. Crohn's Disease and Ulcerative Colitis2017; : 639 doi: 10.1007/978-3-319-33703-6_60
71
Martina Nebbia, Nuha A. Yassin, Antonino Spinelli. Colorectal Cancer in Inflammatory Bowel DiseaseClinics in Colon and Rectal Surgery 2020; 33(05): 305 doi: 10.1055/s-0040-1713748
72
Markus F. Neurath. Mucosal Immunology2015; : 1613 doi: 10.1016/B978-0-12-415847-4.00082-3
73
Rosario Fornaro, Michela Caratto, Elisa Caratto, Giuseppe Caristo, Francesco Fornaro, Davide Giovinazzo, Camilla Sticchi, Marco Casaccia, Enzo Andorno. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance ProgramClinical Colorectal Cancer 2016; 15(3): 204 doi: 10.1016/j.clcc.2016.02.002
74
Xuexiu He, Zhengkai Wei, Jingjing Wang, Jinhua Kou, Weijian Liu, Yunhe Fu, Zhengtao Yang. Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitisScientific Reports 2016; 6(1) doi: 10.1038/srep28370
75
Wei Dou, Jingjing Zhang, Gaiyan Ren, Lili Ding, Aning Sun, Chao Deng, Xiaojun Wu, Xiaohui Wei, Sridhar Mani, Zhengtao Wang. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivationInternational Immunopharmacology 2014; 23(1): 170 doi: 10.1016/j.intimp.2014.08.025
76
Camila Estay, Daniela Simian, Jaime Lubascher, Carolina Figueroa, Andrés O'Brien, Rodrigo Quera. Ionizing radiation exposure in patients with inflammatory bowel disease: Are we overexposing our patients?Journal of Digestive Diseases 2015; 16(2): 83 doi: 10.1111/1751-2980.12213
77
Anita L. Ray, Eliseo F. Castillo, Katherine T. Morris, Robert A. Nofchissey, Lea L. Weston, Von G. Samedi, Joshua A. Hanson, Matthias Gaestel, Irina V. Pinchuk, Ellen J. Beswick. Blockade of MK2 is protective in inflammation-associated colorectal cancer developmentInternational Journal of Cancer 2016; 138(3): 770 doi: 10.1002/ijc.29716
78
Amarender Puri, Vaishali Bharadwaj, Sanjeev Sachdeva. Extent of disease is a major outcome predictor in patients with ulcerative colitis and pregnancyIndian Journal of Gastroenterology 2015; 34(2): 108 doi: 10.1007/s12664-015-0542-y
79
Jianfeng Gong, Lijing Zhu, Zhen Guo, Yi Li, Weiming Zhu, Ning Li, Jieshou Li, Christopher R. Weber. Use of Thiopurines and Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Diseases: A Meta-AnalysisPLoS ONE 2013; 8(11): e81487 doi: 10.1371/journal.pone.0081487
80
Paulo Freire, Pedro Figueiredo, Ricardo Cardoso, Maria Manuel Donato, Manuela Ferreira, Sofia Mendes, Mário Rui Silva, Maria Augusta Cipriano, Ana Margarida Ferreira, Helena Vasconcelos, Francisco Portela, Carlos Sofia. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis – a cross-sectional studyScandinavian Journal of Gastroenterology 2014; 49(10): 1219 doi: 10.3109/00365521.2014.951390
81
David N. Floyd, Sue Langham, Hélène Chevrou Séverac, Barrett G. Levesque. The Economic and Quality-of-Life Burden of Crohn’s Disease in Europe and the United States, 2000 to 2013: A Systematic ReviewDigestive Diseases and Sciences 2015; 60(2): 299 doi: 10.1007/s10620-014-3368-z
82
Ammar Hassanzadeh Keshteli, Vickie E Baracos, Karen L Madsen. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: A reviewWorld Journal of Gastroenterology 2015; 21(4): 1081-1090 doi: 10.3748/wjg.v21.i4.1081
83
Jessica Bogach, Gregory Pond, Cagla Eskicioglu, Hsien Seow. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease–Associated Colorectal Cancer: A Population-Based Cohort StudyInflammatory Bowel Diseases 2019; 25(12): 1957 doi: 10.1093/ibd/izz088
84
Vincenzo Formica, Jessica Luccchetti, David Cunningham, Elizabeth C. Smyth, Patrizia Ferroni, Antonella Nardecchia, Manfredi Tesauro, Vittore Cereda, Fiorella Guadagni, Mario Roselli. Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patientsMedical Oncology 2014; 31(9) doi: 10.1007/s12032-014-0166-6
85
Loris R Lopetuso, Valentina Petito, Tiziano Zinicola, Cristina Graziani, Viviana Gerardi, Vincenzo Arena, Maria Emiliana Caristo, Andrea Poscia, Giovanni Cammarota, Alfredo Papa, Valerio Cufino, Alessandro Sgambato, Antonio Gasbarrini, Franco Scaldaferri. Infliximab does not increase colonic cancer risk associated to murine chronic colitisWorld Journal of Gastroenterology 2016; 22(44): 9727-9733 doi: 10.3748/wjg.v22.i44.9727
86
Niccolò Petrucciani, Nicola de’Angelis, Federica Gaiani, Francesco Brunetti. Emergency Surgical Management of Colorectal CancerHot Topics in Acute Care Surgery and Trauma 2019; : 201 doi: 10.1007/978-3-030-06225-5_18
87
Samuel Achilefu, Ramesh Raghavachari, Jelena M. Janjic, Ales Berlec, Christina Bagia, Lu S. Liu, Irenej Jeric, Michael Gach, Bratislav M. Janjic, Borut Strukelj. NIR and MR imaging supported hydrogel based delivery system for anti-TNF alpha probiotic therapy of IBDReporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications VIII 2016; 9723: 972309 doi: 10.1117/12.2213376
88
Bo Jiang, Ting Zhang, Fen Liu, Zhangzhang Sun, Hanping Shi, Dong Hua, Chen Yang. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancerOncotarget 2016; 7(22): 31755 doi: 10.18632/oncotarget.9035
89
Emily Jean Poulin, Jeanne Shen, Jessica J. Gierut, Kevin M. Haigis. Pathology and Epidemiology of Cancer2017; : 409 doi: 10.1007/978-3-319-35153-7_22
90
D. H. Johnson, S. Khanna, T. C. Smyrk, E. V. Loftus, K. S. Anderson, D. W. Mahoney, D. A. Ahlquist, J. B. Kisiel. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitisAlimentary Pharmacology & Therapeutics 2014; 39(12): 1408 doi: 10.1111/apt.12774
91
Diana Costa Bento, Emma Jones, Syed Junaid, Justyna Tull, Geraint T Williams, Andrew Godkin, Ann Ager, Awen Gallimore. High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progressionOncoImmunology 2015; 4(3): e974374 doi: 10.4161/2162402X.2014.974374
92
Taku Maejima, Toru Kono, Fumika Orii, Atsuo Maemoto, Shigeru Furukawa, Wang Liming, Shoji Kasai, Susumu Fukahori, Nobutaka Mukai, Daitaro Yoshikawa, Hidenori Karasaki, Hiroya Saito, Kazuo Nagashima. Anal Canal Adenocarcinoma in a Patient with Longstanding Crohn’s Disease Arising From Rectal Mucosa that Migrated From a Previously Treated Rectovaginal FistulaAmerican Journal of Case Reports 2016; 17: 448 doi: 10.12659/AJCR.897876
93
Morgane Sébert, Nuria Sola-Tapias, Emmanuel Mas, Frédérick Barreau, Audrey Ferrand. Protease-Activated Receptors in the Intestine: Focus on Inflammation and CancerFrontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00717
94
João Rocha, Rosa Direito, Ana Lima, Joana Mota, Margarida Gonçalves, Maria Paula Duarte, João Solas, Bruno Felício Peniche, Adelaide Fernandes, Rui Pinto, Ricardo Boavida Ferreira, Bruno Sepodes, Maria-Eduardo Figueira. Reduction of inflammation and colon injury by a Pennyroyal phenolic extract in experimental inflammatory bowel disease in miceBiomedicine & Pharmacotherapy 2019; 118: 109351 doi: 10.1016/j.biopha.2019.109351
95
Ruimin Tian, Xianfeng Liu, Yanqin Luo, Shengnan Jiang, Hong Liu, Fengming You, Chuan Zheng, Jiasi Wu. Apoptosis Exerts a Vital Role in the Treatment of Colitis-Associated Cancer by Herbal MedicineFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00438
96
Jong-Min Park, Na Young Han, Young-Min Han, Mi Kyung Chung, Hoo Keun Lee, Kwang Hyun Ko, Eun-Hee Kim, Ki Baik Hahm. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics?World Journal of Gastroenterology 2014; 20(37): 13466-13476 doi: 10.3748/wjg.v20.i37.13466